Toxic shock-like syndrome (TSLS) is characterized by hypotension or shock, fever, multiorgan system involvement, and a concurrent group A streptococcal infection. We analyzed 34 streptococcal strains isolated from patients with clinically well-documented TSLS for their pyrogenic toxin profiles and M-protein types. Although strains of nine different M types were represented in the sample, 74% of the isolates were of either M type 1 or 3. It was determined that 53% produced streptococcal pyrogenic exotoxin type A under in vitro growth conditions and that 85% contained the gene encoding this toxin. These values are in contrast to the published value of 15% for the incidence of this gene in a sample of general group A streptococcal isolates. As has been found with all group A streptococci examined to date, regardless of disease association, 100% of TSLS-associated isolates contained the gene encoding pyrogenic exotoxin type B. This toxin was detectably produced by 59% of isolates. The gene encoding pyrogenic toxin type C was found in only 21% of isolates. We conclude that the pyrogenic exotoxin type A gene is associated with group A streptococcal strains isolated from patients with TSLS and may play a causative role in this illness. However, other factors are also likely to be important, since not all strains from patients with TSLS contained the A toxin gene.
In recent years numerous cases of a toxic shock-like syndrome (TSLS) caused by Streptococcus pyogenes have been reported (1, 6, 13, 30) . Complications characteristic of the syndrome include hypotension or shock, fever, renal impairment, hypoalbuminemia, hypocalcemia, respiratory failure, vomiting and diarrhea, rash, and a concurrent group A streptococcal infection (30) . The illness progresses rapidly and is usually quite severe, as indicated by the 30% mortality rate observed by Stevens et al. (30) .
The multiorgan involvement typical of this illness even in the absence of bacteremia indicates that a toxin(s) may be involved in its pathogenesis. Indeed, the similarities between the complications given above and those seen in staphylococcal toxic shock syndrome (TSS) implicate a pyrogenic toxin.
Pyrogenic toxins are a group of acid-stable single-chain proteins ranging in molecular weight from 20,000 to 40,000. This group includes the staphylococcal enterotoxin serotypes A to E (SEA to SEE), the staphylococcal pyrogenic exotoxins A and B, toxic shock syndrome toxin type 1 (TSST-1), and the streptococcal pyrogenic exotoxin types A to C (SPE A to SPE C). These toxins are characterized by their similar biological activities: they induce fever, are nonspecific T-cell mitogens, enhance host susceptibility to endotoxin, suppress B-lymphocyte function, and cause a scarlet fever-like rash (3, 29, 33) . Some members of the group, such as SPE A, SEB, and SEC, share significant sequence similarity (15) . At least four of the staphylococcal pyrogenic toxins have been shown to play a significant role * Corresponding author.
in the pathogenesis of staphylococcal TSS (21, 23, 24) , whereas the SPEs, formerly called the scarlet fever toxins, have been shown to be important in the development of scarlet fever (7, 20) .
The reason for the recent appearance of streptococcal TSLS has been the subject of much conjecture. Stevens et al. (30) have proposed that the syndrome is caused by streptococci elaborating SPE A and that the current outbreaks are due to the reemergence of strains capable of producing this toxin. However, TSLS-associated strains producing SPE B, SPE C, or both but not SPE A have been reported (4, 6, 30) . It is also possible that the syndrome results from changing host susceptibility and immunity, selective antibiotic pressures, or a streptococcal antigen other than the SPEs.
This study was undertaken to examine a collection of TSLS-associated group A streptococcal isolates for their M-protein types, their toxin production profiles, and the presence of genes encoding the individual SPEs. The correlation between these characteristics and the M-protein serotypes of the strains was also investigated.
MATERIALS AND METHODS
Bacterial isolates. Thirty-four S. pyogenes strains reportedly isolated from patients with TSLS were submitted to our laboratories by physicians from 1986 through 1990. The patients were from diverse locations within the United States. For this study, the following working definition of TSLS was used: hypotension or shock, fever, and multiorgan system involvement concurrent with a group A streptococcal infection. The (10, 14, 19, 32) .
Ouchterlony immunodiffusion assays. Streptococci were grown to the stationary phase in 50 ml of dialyzable beef heart medium at 37°C in the presence of 7% carbon dioxide. When indicated, isolates were also grown in either 50 ml of dialyzable beef heart medium supplemented with 5% fetal bovine serum or additional glucose and glutamine or in 50 ml of Todd-Hewitt (Difco, Detroit, Mich.) medium. The broth was then treated with 200 ml of ethanol to precipitate toxins. Precipitates were dried and resuspended in 0.5 ml of distilled water, and insoluble material was removed by centrifugation in a microfuge for 10 min. At this stage, some supernatants were digested with hyaluronidase (600 U for 2 h at 37°C; Sigma Chemical Co., St. Louis, Mo.). The supernatants (20 ,ul) were tested for their reactivities with specific toxin antisera from rabbits by Ouchterlony immunodiffusion (22 Toxin gene probes. Toxin gene probes were obtained as diagrammed in Fig. 1 . An approximately 500-bp internal DNA probe specific for speA, the gene encoding SPE A, was obtained by digesting pUMN107 (formerly pJS107) (17) with BamHI and BglII. A probe specific for speB, the gene which encodes SPE B, was obtained as follows. pUMN720 (12) DNA was digested with KpnI and ClaI. The resulting 612-bp fragment was an internal portion of speB. Probe DNA used to detect specifically speC, the gene which encodes SPE C, was obtained as follows. pUMN521 (9) was digested with
DdeI to obtain a 654-bp fragment which includes a large part of the speC structural gene and 34 bp 3' to the speC stop codon. speA, speB and speC have little similarity between one another; therefore, it was expected that these probes would not cross-hybridize. This was confirmed by hybridization studies with streptococcal chromosomal DNA containing all three pyrogenic toxin genes (data not shown).
All digested plasmids were electrophoresed in agarose gels, and the appropriately sized fragments were extracted (27 To investigate the possibility that some streptococcal isolates at one time contained speA but lost this gene during passaging, the in vitro stability of the speA genotype was examined and found to be stable even after 20 passages. (Fig. 3) . The same probe hybridized to 4.3-and 3.3-kb fragments of similarly digested chromosomal DNA purified from M type 3 strains. A different toxin restriction fragment length polymorphism (RFLP) was detected for nearly every M type examined in this study (Table 2) . SPE C. Because of the relatively weak immunogenicity of SPE C, we were unable to reliably detect SPE C by the Ouchterlony immunodiffusion assay.
Hybridization results for chromosomal DNA from selected isolates with the speC probe indicated that only 21% of tested strains contained a speC-hybridizing gene. Since no two of these isolates were of the same M type, it was not possible to determine whether the RFLPs of this gene remained uniform within isolates of a particular M type. The pattern, however, did differ between M types (Table 2) .
DISCUSSION
The majority (74%) of TSLS-associated group A streptococcal isolates were of M-protein types 1 or 3. Interestingly, these are the same two M types which have been associated with many of the streptococci isolated from recent acute rheumatic fever outbreaks in the United States (18) . Gaworzewska and Colman (8) have reported that, in England, group A streptococcal isolates of M types 6, 49, and 81 increased and then decreased in frequency and were replaced by M types 1, 3, and 28 in the latter half of the 1980s. A similar emergence of streptococci of these M types appears to have occurred in the United States (14a) and may explain, in part, the high frequency of TSLS-associated organisms with these M types. A significant number of isolates, however, were of M types other than 1 and 3, making it unlikely that any factor responsible for the pathogenesis of TSLS is uniquely associated with one or two particular serotypes.
Our experiments indicate that speA is associated with TSLS. Of 34 isolates tested, 29 (85%) were shown to contain DNA sequences which hybridized to an internal speA probe. In contrast, a recent study (34) indicated that only 15% of group A streptococcal strains isolated from patients with a variety of illnesses contain speA. SPE A is an attractive candidate for playing a role in the pathogenesis of TSLS, since it shares many of the biological properties of TSST-1 and SEB, the major causative toxins of staphylococcal TSS. SPE A shares approximately 50% sequence similarity with SEB (15) . Also, speA is carried by a phage (16) and is thus easily disseminated to streptococci of a variety of serotypes.
Interestingly, the majority of M type 1 strains examined in this study elaborated very small amounts of or no SPE A, such that this toxin could not be reliably detected by Ouchterlony immunodiffusion when these strains were grown in vitro. SPE A production was correlated perfectly with the presence of a speA-hybridizing sequence in all other serotypes except a single M type 18 isolate. SPE A production may be down-regulated under in vitro growth conditions in M type 1 organisms. This would result in the underestimation of SPE A-producing organisms in previously published reports on TSLS, which relied on Ouchterlony immunodiffusion assays for toxin testing (4, 6, 30) . Expression of SPE A in these isolates was not affected by growth in Todd-Hewitt medium or dialyzable beef heart medium with or with out 5% fetal bovine serum, additional glucose, or glutamine; these last three supplements have, at times, been used to amplify toxin production. Thus, we were unable to rule out the possibility that this toxin was also not expressed in vivo from these strains. It may be that the toxin is expressed at normal levels but is bound by hyaluronic acid upon excretion and, therefore, is unable to diffuse into the agarose during Ouchterlony immunodiffusion assays (25) . VOL. 29, 1991 on July 5, 2017 by guest http://jcm.asm.org/
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However, treatment of bacterial broth precipitates with hyaluronidase had no effect on toxin assay results. Alternatively, it is possible that the M type 1 streptococci examined in this study elaborate a previously undescribed toxin which shares a limited number of epitopes with SPE A, accounting for its diminished antibody reactivity. Finally, the toxin may be either intrinsically unstable or degraded by a bacterial protease. The similarity of the toxin RFLPs of non-SPE A-producing M type 1 strains with those of M type 1 strains which produce this toxin suggests that these isolates may have the potential to produce SPE A. Further studies are necessary to fully elucidate the expression of speA in M type 1 streptococci. Even with the absence of detectable SPE A production by these strains, 53% of TSLS-associated isolates elaborated this toxin in vitro.
It has been postulated that the current outbreaks of TSLS are due to the resurgence of group A streptococcal strains which produce SPE A (6, 30 
